| Metric | FY2025 | FY2024 |
|---|---|---|
| REVENUE | $113K | — |
| General and administrative | $9.6M+171.7% | $3.5M |
| Research and development | $601K-21.0% | $760K |
| Sales and marketing | $229K-13.9% | $266K |
| Total operating expenses | $10.5M+128.9% | $4.6M |
| Interest expense | -$687K-14687.9% | -$5K |
| Other income | $108K+174.4% | $39K |
| Change in fair value of derivative liabilities | $1.5M | — |
| Accretion of debt discount | -$250K | — |
| Loss on conversion of convertible notes payable | -$3.3M | — |
| Realized gain on investments | $133K | — |
| Total other income (expenses) | -$2.5M-7201.0% | $35K |
| NET LOSS BEFORE TAXES | -$12.8M-182.7% | -$4.5M |
| NET LOSS | -$12.8M-182.7% | -$4.5M |
| Net loss per share: Basic | -$0.40-150.0% | -$0.16 |
| Net loss per share: Diluted | -$0.40-150.0% | -$0.16 |
| Weighted average common shares outstanding: Basic | 32.2M+11.1% | 29.0M |
| Weighted average common shares outstanding: Diluted | 32.2M+11.1% | 29.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.